CoChat

8-Aminoquinoline Therapy for Latent Malaria

Baird, J. Kevin · 2019 · Clinical Microbiology Reviews
Cited by 122

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

The technical genesis and practice of 8-aminoquinoline therapy of latent malaria offer singular scientific, clinical, and public health insights. The 8-aminoquinolines brought revolutionary scientific discoveries, dogmatic practices, benign neglect, and, finally, enduring promise against endemic malaria.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/cmr.00011-19

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 322

  1. World Health Organization. 2015. Control and elimination of Plasmodium vivax malaria: a technical brief, p 64. World Health Organization, Geneva, Switzerland.
  2. 10.1016/B978-0-12-397900-1.00003-7 · DOI · Paper page
  3. 10.1371/journal.pntd.0003071 · DOI · Paper page
  4. 10.4269/ajtmh.17-0131 · DOI
  5. 10.4269/ajtmh.16-0171 · DOI
  6. Young MD. 1944. Studies on the periodicity of induced Plasmodium vivax. J Natl Malar Soc 3:237–247.
  7. 10.1016/B978-0-12-397900-1.00002-5 · DOI · Paper page
  8. 10.1136/bmj.2.2115.77 · doi:10.1136/bmj.2.2115.77
  9. 10.1093/jac/36.5.857 · DOI
  10. Sinton JA. 1930. A suggested standard treatment of malaria based upon the results of the controlled investigation of over 3,700 cases. Ind Med Gaz 65:603–620.
  11. Slater L. 2013. War and disease: biomedical research on malaria in the twentieth century. Rutgers University Press, New Brunswick, NJ.
  12. 10.1128/AAC.01296-10 · DOI
  13. Shannon JA. 1946. Chemotherapy in malaria. Bull N Y Acad Med 22:345–357.
  14. Wiselogle FY. 1946. A survey of antimalarial drugs 1941–1945. J. W. Edwards, Ann Arbor, MI.
  15. Carson PE, Hohl R, Nora MV, Parkhurst GW, Ahmad T, Scanlan S, Frischer H. 1981. Toxicology of the 8-aminoquinolines and genetic factors associated with their toxicity in man. Bull World Health Organ 59:427–437.
  16. 10.1353/pbm.2013.0035 · doi:10.1353/pbm.2013.0035
  17. 10.1179/2047773215Y.0000000016 · DOI
  18. 10.1371/journal.pmed.1001339 · DOI · Paper page
  19. 10.1186/s12936-018-2248-y · DOI · Paper page
  20. 10.1371/journal.pmed.1002379 · DOI · Paper page
  21. 10.1186/1475-2875-11-280 · DOI · Paper page
  22. 10.1016/j.tmaid.2015.04.006 · doi:10.1016/j.tmaid.2015.04.006
  23. 10.1128/AAC.01879-12 · DOI
  24. 10.1186/s12916-015-0535-9 · DOI
  25. 10.4269/ajtmh.16-0410 · DOI
  26. 10.1093/cid/ciy319 · DOI · Paper page
  27. Coatney GR, Collins WE, Warren MCW, Contacos PG, 1971. The primate malarias, p 366. Stock no. 1744-0005. U.S. Government Printing Office, Washington, DC.
  28. Lysenko AJ, Beljaev AE, Rybalka VM. 1977. Population studies of Plasmodium vivax. 1. The theory of polymorphism of sporozoites and epidemiological phenomena of tertian malaria. Bull World Health Organ 55:541–549.
  29. Rybalka VM, Beljaev AE, Lysenko AJ. 1977. Population studies of Plasmodium vivax. 2. Distribution of manifestations in foci of tertian malaria. Bull World Health Organ 55:551–556.
  30. 10.1086/512242 · DOI · Paper page
  31. 10.1016/S0035-9203(48)80006-4 · doi:10.1016/s0035-9203(48)80006-4
  32. 10.4269/ajtmh.1982.31.24 · doi:10.4269/ajtmh.1982.31.24
  33. 10.4269/ajtmh.1982.31.609 · doi:10.4269/ajtmh.1982.31.609
  34. 10.4269/ajtmh.1983.32.231 · DOI
  35. 10.1186/s12936-017-1759-2 · DOI
  36. 10.1128/CMR.18.3.570-581.2005 · DOI · Paper page
  37. 10.1186/s12936-016-1605-y · DOI
  38. 10.1128/CMR.00027-07 · DOI · Paper page
  39. World Health Organization. 1961. Chemotherapy of malaria: report of a technical meeting, 14-19 November 1960, p 92. Technical report series no. 226. World Health Organization, Geneva, Switzerland.
  40. 10.1136/bmj.2.5348.27 · doi:10.1136/bmj.2.5348.27
  41. Hendrickse RG. 1976. The quartan malaria nephrotic syndrome. Adv Nephrol 6:229–233.
  42. 10.1371/journal.pntd.0004195 · DOI · Paper page
  43. 10.3201/eid2308.161582 · DOI
  44. 10.4269/ajtmh.2006.75.402 · DOI · Paper page
  45. 10.1016/0035-9203(61)90103-1 · DOI
  46. 10.1128/aac.44.6.1680-1685.2000 · DOI · Paper page
  47. 10.1086/379714 · DOI
  48. 10.1016/j.tmaid.2017.04.005 · DOI
  49. Arnold J, Alving AS, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Flanagan CL, Jeffery GM. 1955. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama, P-F-6 strain). J Lab Clin Med 46:391–397.
  50. 10.1086/424663 · DOI · Paper page
  51. 10.4269/ajtmh.1963.12.121 · DOI · Paper page
  52. 10.4269/ajtmh.1977.26.1116 · DOI
  53. 10.1093/cid/ciy735 · DOI
  54. Clyde DF. 1981. Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bull World Health Organ 59:391–395.
  55. 10.1001/jama.1952.72930340022010b · doi:10.1001/jama.1952.72930340022010b
  56. 10.1001/jama.1952.72930340027010c · doi:10.1001/jama.1952.72930340027010c
  57. Edgcomb JH, Arnold J, Yount EH, Alving AS, Eichelberger L, Jeffery GM, Eyles D, Young MD. 1950. Primaquine, SN 13272, a new curative agent in vivax malaria: a preliminary report. J Natl Malar Soc 9:285–292.
  58. Beutler E. 1959. The hemolytic effect of primaquine and related compounds: a review. J Hematol 24:103–139.
  59. Brennecke FE, Alving AS, Arnold J, Bergenstal DM, DeWind LT. 1951. A preliminary report on the effect of certain 8-aminoquinolines in the treatment of rheumatoid arthritis. J Lab Clin Med 38:795–796.
  60. 10.1111/j.1749-6632.1968.tb11938.x · doi:10.1111/j.1749-6632.1968.tb11938.x
  61. 10.1111/j.1365-2125.1974.tb00235.x · DOI
  62. 10.1016/0006-2952(86)90145-0 · doi:10.1016/0006-2952(86)90145-0
  63. 10.1016/0006-2952(86)90144-9 · doi:10.1016/0006-2952(86)90144-9
  64. 10.1371/journal.pone.0105217 · doi:10.1371/journal.pone.0105217
  65. 10.1016/j.exphem.2013.04.002 · DOI
  66. 10.1073/pnas.1310402110 · doi:10.1073/pnas.1310402110
  67. 10.4269/ajtmh.16-0779 · DOI · Paper page
  68. McChesney JD, Baker JK, Clark AM, Hufford CD. 1987. Primaquine: studies of mammalian metabolism, p 3–26. In Wernsdorfer WH, Trigg PI (ed), Primaquine: pharmacokinetics, metabolism, toxicity, and activity. John Wiley & Sons, Inc, New York, NY.
  69. Strother A, Bucholz J, Abu-El-Haj S, Allahyrari R, Fraser IM. 1987. Metabolism of primaquine by various animal species, p 27–48. In Wernsdorfer WH, Trigg PI (ed), Primaquine: pharmacokinetics, metabolism, toxicity, and activity. John Wiley & Sons, Inc, New York, NY.
  70. Fletcher KA, Price AH, Barton PF. 1987. The pharmacokinetics and biochemical pharmacology of primaquine in rhesus monkeys and rats, p 49–64. In Wernsdorfer WH, Trigg PI (ed), Primaquine: pharmacokinetics, metabolism, toxicity, and activity. John Wiley & Sons, Inc, New York, NY.
  71. 10.1023/A:1016305822808 · doi:10.1023/a:1016305822808
  72. 10.1016/0006-2952(88)90263-8 · DOI
  73. 10.1016/S0021-9258(19)50504-X · DOI · Paper page
  74. 10.1186/1475-2875-12-212 · DOI · Paper page
  75. 10.1128/AAC.00015-15 · doi:10.1128/aac.00015-15
  76. 10.1186/s12936-018-2433-z · doi:10.1186/s12936-018-2433-z
  77. 10.1016/S0940-2993(99)80010-4 · doi:10.1016/s0940-2993(99)80010-4
  78. 10.1111/j.1365-2125.1984.tb02369.x · DOI · Paper page
  79. 10.1016/j.pharmthera.2016.03.011 · DOI · Paper page
  80. 10.1056/NEJMc1301936 · DOI · Paper page
  81. 10.1001/jamanetworkopen.2018.1449 · DOI · Paper page
  82. 10.1186/1475-2875-13-2 · doi:10.1186/1475-2875-13-2
  83. 10.1186/s12936-016-1145-5 · DOI
  84. 10.1186/s12936-016-1632-8 · DOI
  85. 10.1128/aac.48.4.1329-1334.2004 · DOI
  86. 10.4269/ajtmh.1958.7.207 · doi:10.4269/ajtmh.1958.7.207
  87. 10.4269/ajtmh.1999.60.831 · DOI
  88. 10.1111/j.1365-2915.1991.tb00523.x · doi:10.1111/j.1365-2915.1991.tb00523.x
  89. 10.4269/ajtmh.1991.44.564 · DOI
  90. 10.1016/0035-9203(91)90012-n · DOI · Paper page
  91. 10.1016/0035-9203(90)90258-g · DOI · Paper page
  92. 10.1016/0035-9203(76)90132-2 · DOI
  93. Garnham P, Bray RS, Bruce-Chwatt LJ, Draper CC, Killick-Kendrick R, Sergiev PG, Tiburskaja NA, Shute PG, Maryon M. 1975. A strain of Plasmodium vivax characterized by prolonged incubation: morphological and biological characteristics. Bull World Health Organ 52:21–32.
  94. 10.4269/ajtmh.1986.35.263 · doi:10.4269/ajtmh.1986.35.263
  95. 10.1155/2014/347018 · doi:10.1155/2014/347018
  96. 10.1128/CDLI.8.5.891-894.2001 · doi:10.1128/cdli.8.5.891-894.2001
  97. 10.1016/j.chom.2015.02.011 · DOI · Paper page
  98. 10.1016/j.chom.2018.01.002 · DOI
  99. 10.1371/journal.pntd.0002882 · DOI · Paper page
  100. 10.4269/ajtmh.1949.s1-29.203 · DOI
  101. 10.1371/journal.pntd.0003595 · DOI · Paper page
  102. 10.1371/journal.pmed.1001891 · DOI · Paper page
  103. 10.1016/s0035-9203(98)91034-3 · doi:10.1016/s0035-9203(98)91034-3
  104. 10.1016/s0035-9203(98)90814-8 · DOI
  105. 10.1080/00034989957790 · doi:10.1080/00034989957790
  106. 10.1371/journal.pntd.0001979 · DOI
  107. 10.7554/eLife.04692 · DOI · Paper page
  108. 10.4269/ajtmh.2001.64.97 · DOI · Paper page
  109. 10.1016/j.pt.2007.08.011 · DOI · Paper page
  110. 10.4269/ajtmh.2007.77.79 · DOI · Paper page
  111. 10.1590/S0037-86822007000400026 · DOI
  112. 10.1016/j.ijpara.2012.06.006 · doi:10.1016/j.ijpara.2012.06.006
  113. 10.1038/177815a0 · doi:10.1038/177815a0
  114. Ambruster HW. 1947. Treason’s peace: German dyes & American dupes, p 420. The Beechhurst Press, New York, NY.
  115. Ehrlich P. 1880. Methodologische Beiträge zur Physiologie und Pathologie der verschiedenen Formen der Leukocyten. Z Klin Med 1:553–560.
  116. Guttman P, Ehrlich P. 1891. Euber die Wirkung des Methylenblau bei Malaria. Berlin Klin Wochenschr 28:953–956.
  117. 10.1007/s00436-012-2886-x · DOI · Paper page
  118. Dascombe MJ, Drew MGB, Evans PG, Ismail FMD. 2007. Rational design strategies for the development of synthetic quinolone and acridine based antimalarials, p 559–609. In Atta-ur-Rahman, Caldwell GW, Choudhary MI, Player MR (ed), Frontiers in drug design & discovery, vol 3. Bentham Science Publishers, Sharjah, United Arab Emirates.
  119. 10.1017/mdh.2013.69 · DOI
  120. 10.1093/jhmas/jrv009 · DOI
  121. Taylor N. 1945. Cinchona in Java, p 87. Greenberg: Publisher, New York, NY.
  122. van Leersum N. 1945. Chapters in the history of cinchona. III. Junghuhn and cinchona cultivation, p 190–196. In Science and scientists in the Netherlands Indies. Board for the Netherlands Indies, Surinam and Curacao, New York, NY, and Riverside Press, Cambridge, MA.
  123. Sergent ED, Sergent ET. 1921. Avantages de la quinisation preventive demontres et precises experimentellement (Paludisme des oiseaux). Ann Inst Pasteur 35:125–141.
  124. 10.1353/bhm.2005.0092 · doi:10.1353/bhm.2005.0092
  125. Hewitt R. 1940. Bird malaria, p 228. The American Journal of Hygiene monograph series no. 15. The Johns Hopkins Press, Baltimore, MD.
  126. Roehl W. 1926. Die Wirkung des Plasmochins auf die Vogelmalaria. Arch Schiffs Tropenhyg 30:311–318.
  127. 10.4269/ajtmh.1955.4.208 · doi:10.4269/ajtmh.1955.4.208
  128. Field JW. 1938. Notes on the chemotherapy of malaria. VI. Synthetic gametocides of the plasmoquine type. Bull Inst Medical Res Federated Malay States 2:63–79.
  129. Vad BG, Mohile GB. 1927. The place of plasmochin in the treatment of malaria. Ind Med Gaz 62:430–434.
  130. Manson-Bahr P. 1927. The action of plasmochin on malaria. Proc R Soc Med 20:919–926.
  131. Sinton JA, Bird W. 1928. Studies in malaria, with special reference to treatment. Part IX. Plasmoquine in the treatment of malaria. Indian J Med Res 16:159–177.
  132. Cordes W. 1927. Observations on the toxic effects of plasmochin, p 62–67. In Sixteenth annual report of the Medical Department of the United Fruit Company. United Fruit Company, Boston, MA.
  133. Brosius OT. 1927. Plasmochin in malaria, p 26–53. In Sixteenth annual report of the Medical Department of the United Fruit Company. United Fruit Company, Boston, MA.
  134. 10.4269/ajtmh.1947.s1-27.309 · doi:10.4269/ajtmh.1947.s1-27.309
  135. 10.1172/JCI101947 · doi:10.1172/jci101947
  136. Sinton JA, Smith S, Pottinger D. 1930. Studies on malaria with special reference to treatment. XII. Further researches into the treatment of chronic benign tertian malaria with plasmoquine and quinine. Indian J Med Res 17:793–814.
  137. 10.1172/JCI101963 · doi:10.1172/jci101963
  138. Alving AS, Arnold J, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Flanagan CL. 1955. Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. J Lab Clin Med 46:301–306.
  139. Phelps BM. 1927. Clinical results with plasmochin, p 70–76. In Sixteenth annual report of the Medical Department of the United Fruit Company. United Fruit Company, Boston, MA.
  140. 10.1186/1475-2875-10-212 · doi:10.1186/1475-2875-10-212
  141. 10.1128/aac.27.2.151 · doi:10.1128/aac.27.2.151
  142. 10.4269/ajtmh.2011.11-0498 · doi:10.4269/ajtmh.2011.11-0498
  143. MacPhail NP. 1927. Plasmochin in malaria, p 67–69. In Sixteenth annual report of the Medical Department of the United Fruit Company. United Fruit Company, Boston, MA.
  144. 10.1172/JCI101948 · doi:10.1172/jci101948
  145. Shannon JA. 1945. Study of the curative action of plasmochin in vivax malaria, p 38. In Malaria report #358, parts 1 and II. 16 March. Board for the Coordination of Malaria Studies, Washington, DC.
  146. 10.1172/JCI101950 · doi:10.1172/jci101950
  147. 10.1172/JCI101955 · doi:10.1172/jci101955
  148. Lysenko AY. 1960. Use of quinocide in the treatment and prophylaxis of vivax malaria. Bull World Health Organ 22:641–662.
  149. Alving AS, Eichelberger L, Arnold J, Edgcomb J. 1949. The clinical testing of antimalarial drugs at Stateville Penitentiary. In Semi-annual report 1948-49. NIH malaria report no. 87. National Academy of Sciences Archive for the Board for Coordination of Malaria Studies, Washington, DC.
  150. 10.1128/AAC.03704-14 · DOI
  151. 10.1128/AAC.02794-13 · doi:10.1128/aac.02794-13
  152. 10.1128/AAC.03829-14 · doi:10.1128/aac.03829-14
  153. 10.1093/jac/dky297 · doi:10.1093/jac/dky297
  154. 10.1186/s12936-016-1509-x · doi:10.1186/s12936-016-1509-x
  155. Sinton JA. 1927. Studies in malaria with special reference to treatment. Part VII. The intravenous infection of sodium stovarsol in the treatment of benign tertian malaria. Indian J Med Res 15:287–299.
  156. 10.1126/science.101.2624.377 · doi:10.1126/science.101.2624.377
  157. 10.4269/ajtmh.1953.2.970 · doi:10.4269/ajtmh.1953.2.970
  158. 10.4269/ajtmh.1996.55.243 · DOI · Paper page
  159. Jensen M, Mehlhorn H. 2009. 75 years of resochin in the fight against malaria, p 102. Dusseldorf University Press, Dusseldorf, Germany.
  160. Sweeney T. 2003. Malaria frontline: Australian Army research during World War II, p 398. Melbourne University Press, Melbourne, Australia.
  161. 10.1001/jama.1943.82840390004007 · doi:10.1001/jama.1943.82840390004007
  162. Butler AM. 1945. Clinical toxicity of plasmocide (SN-3115; rhodoquine): review of the Russian and French literature, p 8. In Malaria report no. 401. 9 May. Board for the Coordination of Malarial Studies. Washington, DC.
  163. 10.1097/00005072-194810000-00002 · doi:10.1097/00005072-194810000-00002
  164. Schmidt LH. 1945. The toxicities of the 8-aminoquinolines: relation of structure to the toxicity of these drugs for the monkey, p 19. In Malaria report no. 469. 19 July. Board for the Coordination of Malarial Studies. Washington, DC.
  165. 10.1172/JCI101973 · doi:10.1172/jci101973
  166. 10.1172/JCI101956 · doi:10.1172/jci101956
  167. 10.1093/oxfordjournals.aje.a119180 · doi:10.1093/oxfordjournals.aje.a119180
  168. 10.4269/ajtmh.1953.2.977 · doi:10.4269/ajtmh.1953.2.977
  169. 10.4269/ajtmh.1953.2.985 · doi:10.4269/ajtmh.1953.2.985
  170. 10.1021/ja01212a039 · doi:10.1021/ja01212a039
  171. 10.4269/ajtmh.1953.2.949 · doi:10.4269/ajtmh.1953.2.949
  172. 10.1172/JCI101970 · doi:10.1172/jci101970
  173. 10.1001/jama.1952.72930340021010a · doi:10.1001/jama.1952.72930340021010a
  174. 10.1001/jama.1952.72930340017010 · doi:10.1001/jama.1952.72930340017010
  175. 10.1001/jama.1954.02940510011005 · doi:10.1001/jama.1954.02940510011005
  176. 10.1172/JCI101949 · doi:10.1172/jci101949
  177. 10.1385/1-59259-111-6:123 · doi:10.1385/1-59259-111-6:123
  178. 10.4269/ajtmh.1998.58.645 · DOI · Paper page
  179. Davidson DE, Jr, Ager AL, Brown BL, Chapple FE, Whitmire RE, Rossan RN. 1981. New tissue schizontocidal antimalarial drugs. Bull World Health Organ 59:463–479.
  180. 10.4269/ajtmh.1970.19.27 · doi:10.4269/ajtmh.1970.19.27
  181. 10.1016/S1471-4922(03)00005-9 · DOI · Paper page
  182. Schultz MG. 1974. Imported malaria. Bull World Health Organ 50:329–336.
  183. 10.4269/ajtmh.1969.18.495 · doi:10.4269/ajtmh.1969.18.495
  184. 10.1186/1475-2875-11-122 · DOI · Paper page
  185. 10.7205/milmed.170.4s.12 · DOI
  186. 10.1016/0020-711X(84)90086-7 · doi:10.1016/0020-711x(84)90086-7
  187. 10.1016/0020-711X(84)90087-9 · doi:10.1016/0020-711x(84)90087-9
  188. 10.1016/0272-0590(88)90311-9 · doi:10.1016/0272-0590(88)90311-9
  189. 10.1021/jm00351a017 · doi:10.1021/jm00351a017
  190. 10.1021/jm00390a012 · doi:10.1021/jm00390a012
  191. 10.1021/jm00351a018 · doi:10.1021/jm00351a018
  192. 10.4269/ajtmh.1989.40.235 · doi:10.4269/ajtmh.1989.40.235
  193. Marino MT, Peggins JO, Brown LD, Urquhart MR, Brewer TG. 1994. Pharmacokinetics and kinetic-dynamic modelling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511). Drug Metab Dispos 22:358–366.
  194. 10.1177/014107689909200705 · doi:10.1177/014107689909200705
  195. 10.1007/BF03161194 · doi:10.1007/bf03161194
  196. 10.1128/AAC.42.5.1293 · doi:10.1128/aac.42.5.1293
  197. 10.1086/315034 · doi:10.1086/315034
  198. 10.1086/324081 · DOI · Paper page
  199. 10.1016/S0140-6736(00)02352-7 · DOI
  200. Edstein MD, Walsh DS, Eamsila C, Sasiprapha T, Nasveld PE, Kitchener S, Reickmann KH. 2001. Malaria prophylaxis/radical cure: experiences of the Australian Defence Force. Med Trop (Mars) 61:56–58.

200 of 322 shown

Cited by

See all 122

Metadata

Authors
Baird, J. K.
Affiliations
Eijkman-Oxford Clinical Research Unit, Eijkman Institute for Molecular Biology, Jakarta, Indonesia
Venue
Clinical Microbiology Reviews
Published
2019-09-18
Volume
32
Issue
4
ISSN
  • 0893-8512
  • 1098-6618
Cited by
122
References
12
Language
en
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Funders
United Kingdom Clinical Research Collaboration (ABCDEFG123456)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 8-Aminoquinoline Therapy for Latent Malaria. https://app.cochat.ai/papers/10.1128/cmr.00011-19
The paper
Baird, J. K. (2019). 8-Aminoquinoline Therapy for Latent Malaria. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00011-19

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.